Inovio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
INO Inovio Pharmaceuticals Inc
CX Cemex SAB de CV
TPRE Third Point Reinsurance Ltd
BAC Bank of America Corp
KVHI KVH Industries Inc
SUP Superior Industries International Inc
FB Facebook Inc
V Visa Inc
FL Foot Locker Inc
DPZ Domino's Pizza Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Premarket

Last Trade
Delayed
$5.17
0.81 (18.58%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.36
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
37,988

10-day average volume:
17,151,335
37,988
  • Prev Close
    4.36
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    17.2M
  • Last (time)
    3:59p ET 02/27/20
  • Last (size)
    76
  • 52-Wk Range
    1.92 - 5.95
    LowHigh
  • (10/02/19 - 01/27/20)
    26.72%
  • 81.2%
  • Market Cap
    441.9M
  • Shares Outstanding
    101.4M
  • -1.18
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.2
  • 42.25
  • (% of float 02/15/20)
    13.80

Latest News

February 24, 2020
9:31 am ET
PR Newswire
February 18, 2020
9:31 am ET
PR Newswire
February 11, 2020
8:40 am ET
PR Newswire
February 10, 2020
6:00 am ET
PR Newswire
February 04, 2020
9:00 am ET
PR Newswire
February 03, 2020
8:00 am ET
PR Newswire
January 31, 2020
9:31 am ET
PR Newswire
January 30, 2020
8:30 am ET
PR Newswire
6:00 am ET
PR Newswire
4:22 am ET
Globe Newswire
January 29, 2020
10:51 am ET
PR Newswire
January 27, 2020
8:55 am ET
PR Newswire
8:43 am ET
MarketWatch
January 25, 2020
10:58 am ET
MarketWatch
January 24, 2020
8:23 am ET
MarketWatch
7:24 am ET
MarketWatch
January 23, 2020
9:15 am ET
PR Newswire
January 21, 2020
2:40 pm ET
MarketWatch
January 15, 2020
8:00 am ET
PR Newswire
January 07, 2020
12:31 pm ET
BusinessWire
January 06, 2020
8:00 am ET
PR Newswire
December 11, 2019
9:52 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.